Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations

Area of Science:

• Nephrology
• Radiology
• Dermatology

Background:

• Nephrogenic systemic fibrosis (NSF) emerged in 2000, linked to renal disease and gadolinium contrast agents.
• Despite extensive research, precise causation and risk factors for NSF require further elucidation.
• The need for objective diagnostic criteria is critical for epidemiological studies.

Purpose of the Study:

• To develop a standardized clinicopathological diagnostic system for Nephrogenic Systemic Fibrosis (NSF).
• To provide clear and objective criteria for the diagnosis of NSF, aiding research and clinical practice.

Main Methods:

• A consensus scoring system was developed by NSF diagnostic experts.
• The system incorporates a clinical and histopathological atlas for standardized evaluation.
• The Yale International NSF Registry resources were utilized.

Main Results:

• A consensus scoring system was devised to guide and standardize NSF evaluation and diagnosis.
• The system integrates clinical and histopathological data for comprehensive assessment.
• This approach facilitates reproducible and accurate diagnosis.

Conclusions:

• No definitive laboratory test exists for diagnosing NSF.
• A clinicopathological definition, based on consensus expertise, serves as a working diagnostic standard.
• This definition aids in excluding mimicking conditions and facilitates accurate diagnosis for physicians, including those with limited experience.